BMS-820836
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BMS-820836, covering 2011-01-25 to 2015-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression [Phase 2]